22 medical stores raided in Hisar, 7 stocked dual-use drugs without records

Hisar: Police and drug control teams raided 22 medical stores across Hisar district in a crackdown on misuse of medicines as intoxicants. Seven outlets were found stocking dual-use drugs without proper records, while registered pharmacists were absent at three stores, officials said.

Teams of 11 drug control officers from eight districts, along with police, inspected stores in Barwala, Uklana, Adampur, Agroha and Hisar city. They checked stocks and mandatory purchase, sale and stock records, and collected 14 medicine samples for testing.

The licensing authority will initiate action under the Drugs and Cosmetics Act against violators. SP Siddhant Jain said surprise joint inspections would continue based on local information and strict action would be taken against those facilitating misuse of medicines.

  • Related Posts

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs